Background Childhood growth hormone treatment has been associated with increased
cardiovascular mortality and morbidity in adults born small for gestational age (SGA) …

Background Growth hormone treatment reduces blood pressure and lipid concentrations.
We assessed long-term changes in blood pressure, lipid concentrations, and carotid intima …

Background Growth hormone treatment reduces fat mass and insulin sensitivity and
increases lean body mass. Data are only available for short-term longitudinal changes after …

To assess the effects of long-term continuous GH treatment on body composition, blood
pressure (BP), and lipid metabolism in children with short stature born small for gestational …

Abstract Background/Aims: An examination of the effects of up to 260 weeks of growth
hormone (GH) therapy on metabolic parameters in Japanese children born small for …

Context We previously reported that short, small for gestational age (SGA) children who
were born preterm have a lower body fat percentage and a higher blood pressure, insulin …

Hyperlipidemia, diabetes mellitus type 2, and coronary heart disease have been associated
with being born small for gestational age (SGA). It has been reported that GH treatment …

Importance Concerns about the cardiovascular safety of recombinant human growth
hormone (rhGH) treatment in childhood have recently been raised; however, long-term …

Background Recombinant human growth hormone has been used for more than 30 years
and its indications have increased worldwide. There is concern that this treatment might …

In this issue of JAMA Pediatrics, Tidblad et al1 report a Swedish nationwide cohort study of
3408 adults who had received growth hormone treatment during childhood from 1985 to …